Etonogestrel
Back to searchMolecule Structure
Scientific Name
Etonogestrel
Description of the Drug
Etonogestrel is a long-acting synthetic derived progestin contraceptive used in various devices such as contraceptive rings and intradermal implants.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00294
http://www.drugbank.ca/drugs/DB00294
Brand Name(s)
Implanon, Nexplanon
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Dr Reddys Laboratories Sa, Organon Usa Llc, Mayne Pharma Llc, Amneal Pharmaceuticals Llc, Organon Usa Llc A Sub Of Organon And Co
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Progesterone receptor | SINGLE PROTEIN | AGONIST | CHEMBL208 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL117703 | |
Human Metabolome Database | HMDB0014439 | |
DrugBank | DB00294 | |
PubChem: Thomson Pharma | 14777213 | 14752897 |
PubChem | 6917715 | |
Nikkaji | J76.212A | |
BindingDB | 50423516 | |
EPA CompTox Dashboard | DTXSID9046782 | |
DrugCentral | 1110 | |
Brenda | 172871 | |
ChemicalBook | CB8146610 | |
Guide to Pharmacology | 7590 | |
rxnorm | NEXPLANON | ETONOGESTREL |
PubChem: Drugs of the Future | 12012881 | |
ChEBI | 50777 | |
ZINC | ZINC000011680067 |